RESEARCH ARTICLE Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses 1,2 1 1 1 John M. PowersID , Nicole N. HaeseID , Michael Denton , Takeshi Ando , 1 1 1 1 Craig Kreklywich , Kiley Bonin , Cassilyn E. StreblowID , Nicholas KreklywichID , 1 1¤ 1 3 Patricia SmithID , Rebecca Broeckel , Victor DeFilippis , Thomas E. MorrisonID , Mark 4 1,5 a1111111111 T. Heise , Daniel N. StreblowID * a1111111111 a1111111111 1 Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America, 2 Department of Molecular and Medical Genetics, Oregon Health and Science University, a1111111111 Portland, Oregon, United States of America, 3 Department of Immunology and Microbiology, University of a1111111111 Colorado School of Medicine, Aurora, Colorado, United States of America, 4 Department of Genetics, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 5 Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America ¤ Current address: Rocky Mountain Laboratories, NIH/NIAID, Hamilton, Montana, United States of America OPEN ACCESS *
[email protected] Citation: Powers JM, Haese NN, Denton M, Ando T, Kreklywich C, Bonin K, et al. (2021) Non- replicating adenovirus based Mayaro virus vaccine Abstract elicits protective immune responses and cross protects against other alphaviruses. PLoS Negl Mayaro virus (MAYV) is an alphavirus endemic to South and Central America associated Trop Dis 15(4): e0009308. https://doi.org/10.1371/ journal.pntd.0009308 with sporadic outbreaks in humans. MAYV infection causes severe joint and muscle pain that can persist for weeks to months.